Neurophet has entered a collaboration to advance software that uses AI to examine brain MRI scans for signs characteristic of ...

The benefits of frexalimab in people with relapsing MS have been sustained for up to three years in a clinical trial, data ...

An app-based peer support program boosted self-confidence and social connection for people newly diagnosed with multiple ...

World MS Day on May 30 unites advocates to push for earlier diagnoses of multiple sclerosis, better medical training, and ...

Neuropsychiatric care in MS has seen major progress over the last 40 years, though more remains to be done, an expert in the ...

Columnist Ben Hofmeister makes a presentation at this year's meeting of the Consortium of Multiple Sclerosis Centers on MS quality of care.

Psychoactive substances like alcohol and caffeine may ease certain MS symptoms, but can make some symptoms worse, a study ...

To many caregivers, moving a spouse into assisted living feels like a failure. For columnist Lindsay Kelly, it was an act of love.

Enrollment has reached 50% in an ongoing study testing whether a PET tracer can reliably measure myelin damage in people with ...

While columnist Ben Hofmeister admittedly is no expert on artificial intelligence and healthcare, he thinks it'll be good for MS research.

The two main mouse models used to study myelin damage and repair in MS each replicate certain distinct biological features of ...